A citation-based method for searching scientific literature

Omkar U Kawalekar, Roddy S O'Connor, Joseph A Fraietta, Lili Guo, Shannon E McGettigan, Avery D Posey, Prachi R Patel, Sonia Guedan, John Scholler, Brian Keith, Nathaniel W Snyder, Ian A Blair, Michael C Milone, Carl H June. Immunity 2016
Times Cited: 409



Michael C Milone, Jonathan D Fish, Carmine Carpenito, Richard G Carroll, Gwendolyn K Binder, David Teachey, Minu Samanta, Mehdi Lakhal, Brian Gloss, Gwenn Danet-Desnoyers, Dario Campana, James L Riley, Stephan A Grupp, Carl H June. Mol Ther 2009
Times Cited: 690




List of shared articles



Times cited


Chimeric antigen receptor T cell therapy in multiple myeloma: promise and challenges.
Binod Dhakal, Parameswaran N Hari, Saad Z Usmani, Mehdi Hamadani. Bone Marrow Transplant 2021
4

Development of CAR T Cells Expressing a Suicide Gene Plus a Chimeric Antigen Receptor Targeting Signaling Lymphocytic-Activation Molecule F7.
Christina Amatya, Melissa A Pegues, Norris Lam, Danielle Vanasse, Claudia Geldres, Stephanie Choi, Stephen M Hewitt, Steven A Feldman, James N Kochenderfer. Mol Ther 2021
10

Development and functional characterization of novel fully human anti-CD19 chimeric antigen receptors for T-cell therapy.
Zhenyu Dai, Xuelian Hu, Xiangyin Jia, Jianwei Liu, Yongkun Yang, Panpan Niu, Guang Hu, Taochao Tan, Jianfeng Zhou. J Cell Physiol 2021
1

Preclinical assessment of the efficacy and specificity of GD2-B7H3 SynNotch CAR-T in metastatic neuroblastoma.
Babak Moghimi, Sakunthala Muthugounder, Samy Jambon, Rachelle Tibbetts, Long Hung, Hamid Bassiri, Michael D Hogarty, David M Barrett, Hiroyuki Shimada, Shahab Asgharzadeh. Nat Commun 2021
6

Genetic engineering of T cells for immunotherapy.
Gavin I Ellis, Neil C Sheppard, James L Riley. Nat Rev Genet 2021
3

Fueling the Revolution: Targeting Metabolism to Enhance Immunotherapy.
Robert D Leone, Jonathan D Powell. Cancer Immunol Res 2021
1

CAR-T cell therapy: current limitations and potential strategies.
Robert C Sterner, Rosalie M Sterner. Blood Cancer J 2021
12

Chimeric antigen receptor natural killer (CAR-NK) cell design and engineering for cancer therapy.
Ying Gong, Roel G J Klein Wolterink, Jianxiang Wang, Gerard M J Bos, Wilfred T V Germeraad. J Hematol Oncol 2021
2

Single-cell multiomics dissection of basal and antigen-specific activation states of CD19-targeted CAR T cells.
Zhiliang Bai, Stefan Lundh, Dongjoo Kim, Steven Woodhouse, David M Barrett, Regina M Myers, Stephan A Grupp, Marcela V Maus, Carl H June, Pablo G Camara,[...]. J Immunother Cancer 2021
1

A comparison of chimeric antigen receptors containing CD28 versus 4-1BB costimulatory domains.
Kathryn M Cappell, James N Kochenderfer. Nat Rev Clin Oncol 2021
3

Determinants of response and mechanisms of resistance of CAR T-cell therapy in multiple myeloma.
Niels W C J van de Donk, Maria Themeli, Saad Z Usmani. Blood Cancer Discov 2021
1

Identifying and managing CAR T-cell-mediated toxicities: on behalf of an Italian CAR-T multidisciplinary team.
Massimo Martino, Sebastiano Macheda, Umberto Aguglia, Luciano Arcudi, Giulia Pucci, Bruno Martino, Maria Altomonte, Antonio Maria Rossetti, Giuseppa Cusumano, Letteria Russo,[...]. Expert Opin Biol Ther 2021
0

PTK7-Targeting CAR T-Cells for the Treatment of Lung Cancer and Other Malignancies.
Yamin Jie, Guijun Liu, Lina Feng, Ying Li, Mingyan E, Liangliang Wu, Yinyin Li, Guanghua Rong, Yongwu Li, Huafeng Wei,[...]. Front Immunol 2021
0

Advances in CAR design.
Amanda Heard, Jufang Chang, John M Warrington, Nathan Singh. Best Pract Res Clin Haematol 2021
0

Improving CAR T-Cell Persistence.
Violena Pietrobon, Lauren Anne Todd, Anghsumala Goswami, Ofir Stefanson, Zhifen Yang, Francesco Marincola. Int J Mol Sci 2021
0

Methods to edit T cells for cancer immunotherapy.
Francesca Lucibello, Silvia Menegatti, Laurie Menger. Methods Enzymol 2020
0

Single residue in CD28-costimulated CAR-T cells limits long-term persistence and antitumor durability.
Sonia Guedan, Aviv Madar, Victoria Casado-Medrano, Carolyn Shaw, Anna Wing, Fang Liu, Regina M Young, Carl H June, Avery D Posey. J Clin Invest 2020
39